Publications by authors named "Mithunan Ravindran"

Article Synopsis
  • Induction chemotherapy (IC) is the standard treatment for newly diagnosed acute myeloid leukemia (AML) patients, but those with adverse-risk may benefit more from a combination of azacytidine and venetoclax (aza-ven).
  • A Markov decision analysis was conducted to compare the effectiveness of IC and aza-ven based on quality-adjusted life years (QALYs) gained in both adverse and intermediate-risk groups.
  • Results showed that adverse-risk patients gained more QALYs with aza-ven (2.0 QALYs) compared to IC (1.4 QALYs), while IC remained the better option for intermediate-risk patients, highlighting the need for further research into aza-ven's effectiveness
View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter aortic valve replacement (TAVR) is widely used to treat severe aortic stenosis, but access to this treatment shows socioeconomic disparities that could affect patient outcomes.
  • A study of over 4,100 patients in Ontario found that higher levels of residential instability were linked to an increased risk of death and hospital readmission one year after the procedure, highlighting a significant health risk associated with this social factor.
  • The research indicates that while residential instability impacts TAVR outcomes, factors like material deprivation and racial or ethnic concentration didn’t show a significant relationship, suggesting a need for targeted interventions to support disadvantaged patients.
View Article and Find Full Text PDF

Background: Despite transcatheter aortic valve implantation (TAVI) becoming a widely accepted therapeutic option for the management of aortic stenosis, post-procedure readmission rates remain high. Rehospitalization is associated with negative patient outcomes, as well as increased healthcare costs, and has therefore been identified as an important target for quality improvement. Strategies to reduce the post-TAVI readmission rate are needed but require the identification of patients at high risk for rehospitalization.

View Article and Find Full Text PDF

Background COVID-19 causes significant morbidity and mortality. Despite the high prevalence of delirium and delirium-related symptoms in COVID-19 patients, data and evidence-based recommendations on the pathophysiology and management of delirium are limited. Objective We conducted a rapid review of COVID-19-related delirium literature to provide a synthesis of literature on the prevalence, pathoetiology, and management of delirium in these patients.

View Article and Find Full Text PDF

The COVID-19 pandemic is responsible for an unprecedented disruption to the healthcare systems and economies of countries around the world. Developing novel therapeutics and a vaccine against SARS-CoV-2 requires an understanding of the similarities and differences between the various human coronaviruses with regards to their phylogenic relationships, transmission, and management. Phylogenetic analysis indicates that humans were first infected with SARS-CoV-2 in late 2019 and the virus rapidly spread from the outbreak epicenter in Wuhan, China to various parts of the world.

View Article and Find Full Text PDF

There is a paucity of literature characterizing the risk of long-term mortality and reintervention after transcatheter aortic valve implantation (TAVI). Addressing this gap has become increasingly relevant with the inclusion of intermediate and low surgical risk patients and the need for data to inform their long-term management. We sought to investigate the long-term trends and predictors of cardiovascular versus noncardiovascular mortality as well as reintervention in post-TAVI patients.

View Article and Find Full Text PDF

Background: There has been rapid growth in the demand for transcatheter aortic valve replacement (TAVR), which has the potential to overwhelm current capacity. This imbalance between demand and capacity may lead to prolonged wait times, and subsequent adverse outcomes while patients are on the waitlist. We sought to understand the relationship between regional differences in capacity, TAVR wait times and morbidity/mortality on the waitlist.

View Article and Find Full Text PDF

Neutrophil extracellular traps (NETs), a unique DNA framework decorated with antimicrobial peptides, have been in the scientific limelight for their role in a variety of pathologies ranging from cystic fibrosis to cancer. The formation of NETs, as well as relevant regulatory mechanisms, physiological factors, and pharmacological agents have not been systematically discussed in the context of their beneficial and pathological aspects. Novel forms of NET formation including vital NET formation continue to be uncovered, however, there remain fundamental questions around established mechanisms such as NADPH-oxidase (Nox)-dependent and Nox-independent NET formation.

View Article and Find Full Text PDF